Alexza Pharmaceuticals (ALXA) and Grupo Ferrer Internacional say the Committee for Medicinal Products for Human Use delivered a positive opinion on recommending European marketing of Adasuve, their treatment for schizophrenia and bipolar disorder. ALXA +19.1% premarket.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs